share_log

Immunovant Expects Top-Line Data for Two Clinical Trials of Batoclimab in Thyroid Eye Disease in 1H 2025 >IMVT

Immunovant Expects Top-Line Data for Two Clinical Trials of Batoclimab in Thyroid Eye Disease in 1H 2025 >IMVT

免疫公司預計2025年上半年巴妥布治療甲狀腺眼病的兩項臨牀試驗的一線數據>IMVT
道瓊斯 ·  2022/08/05 07:15

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論